These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25546515)

  • 21. Impact of CFTR DeltaF508 mutation on prostaglandin E2 production and type IIA phospholipase A2 expression by pulmonary epithelial cells.
    Medjane S; Raymond B; Wu Y; Touqui L
    Am J Physiol Lung Cell Mol Physiol; 2005 Nov; 289(5):L816-24. PubMed ID: 15964894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of wild-type CFTR suppresses NF-kappaB-driven inflammatory signalling.
    Hunter MJ; Treharne KJ; Winter AK; Cassidy DM; Land S; Mehta A
    PLoS One; 2010 Jul; 5(7):e11598. PubMed ID: 20644644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NF-κB and androgen receptor variant expression correlate with human BPH progression.
    Austin DC; Strand DW; Love HL; Franco OE; Jang A; Grabowska MM; Miller NL; Hameed O; Clark PE; Fowke JH; Matusik RJ; Jin RJ; Hayward SW
    Prostate; 2016 Apr; 76(5):491-511. PubMed ID: 26709083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-33 facilitates proliferation of colorectal cancer dependent on COX2/PGE
    Li Y; Shi J; Qi S; Zhang J; Peng D; Chen Z; Wang G; Wang Z; Wang L
    J Exp Clin Cancer Res; 2018 Aug; 37(1):196. PubMed ID: 30119635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of proteinase-activated receptor-2 (PAR2) is androgen-dependent in stromal cell line (hPCPs) from benign prostatic hyperplasia.
    Mannowetz N; Würdinger R; Zippel A; Aumüller G; Wennemuth G
    Prostate; 2010 Sep; 70(12):1350-8. PubMed ID: 20623639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of cell proliferation through a KIT-mediated mechanism in benign prostatic hyperplasia.
    Imura M; Kojima Y; Kubota Y; Hamakawa T; Yasui T; Sasaki S; Hayashi Y; Kohri K
    Prostate; 2012 Oct; 72(14):1506-13. PubMed ID: 22314612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostaglandin E2 upregulates β1 integrin expression via the E prostanoid 1 receptor/nuclear factor κ-light-chain-enhancer of activated B cells pathway in non-small-cell lung cancer cells.
    Bai X; Yang Q; Shu W; Wang J; Zhang L; Ma J; Xia S; Zhang M; Cheng S; Wang Y; Leng J
    Mol Med Rep; 2014 May; 9(5):1729-36. PubMed ID: 24584670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of proliferation and differentiation of prostatic stromal cells by oestradiol through prostatic epithelial cells in a paracrine manner.
    Wu Q; Shi J; Chen L; Wang CY; Park I; Lee C; Zhang J
    BJU Int; 2008 Feb; 101(4):497-502. PubMed ID: 18190643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protease-activated receptor-1 upregulates fibroblast growth factor 7 in stroma of benign prostatic hyperplasia.
    Wang W; Zhang X; Mize GJ; Takayama TK
    Prostate; 2008 Jul; 68(10):1064-75. PubMed ID: 18386288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Down-regulation of the large-conductance Ca(2+)-activated K+ channel, K(Ca)1.1 in the prostatic stromal cells of benign prostate hyperplasia.
    Niwa S; Ohya S; Kojima Y; Sasaki S; Yamamura H; Sakuragi M; Kohri K; Imaizumi Y
    Biol Pharm Bull; 2012; 35(5):737-44. PubMed ID: 22687410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and cellular distribution of TLR4, MyD88, and NF-κB in diabetic renal tubulointerstitial fibrosis, in vitro and in vivo.
    Liu P; Li F; Qiu M; He L
    Diabetes Res Clin Pract; 2014 Aug; 105(2):206-16. PubMed ID: 24894085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacteroides fragilis enterotoxin induces cyclooxygenase-2 and fluid secretion in intestinal epithelial cells through NF-kappaB activation.
    Kim JM; Lee JY; Yoon YM; Oh YK; Kang JS; Kim YJ; Kim KH
    Eur J Immunol; 2006 Sep; 36(9):2446-56. PubMed ID: 16892182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist.
    Rick FG; Abi-Chaker A; Szalontay L; Perez R; Jaszberenyi M; Jayakumar AR; Shamaladevi N; Szepeshazi K; Vidaurre I; Halmos G; Krishan A; Block NL; Schally AV
    Proc Natl Acad Sci U S A; 2013 Feb; 110(7):2617-22. PubMed ID: 23359692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triptolide down-regulates COX-2 expression and PGE2 release by suppressing the activity of NF-κB and MAP kinases in lipopolysaccharide-treated PC12 cells.
    Geng Y; Fang M; Wang J; Yu H; Hu Z; Yew DT; Chen W
    Phytother Res; 2012 Mar; 26(3):337-43. PubMed ID: 21717513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia.
    Cohen P; Peehl DM; Baker B; Liu F; Hintz RL; Rosenfeld RG
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1410-5. PubMed ID: 7525636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclooxygenase-2 activates EGFR-ERK1/2 pathway via PGE2-mediated ADAM-17 signaling in testosterone-induced benign prostatic hyperplasia.
    Abo-El Fetoh ME; Abdel-Fattah MM; Mohamed WR; Ramadan LAA; Afify H
    Inflammopharmacology; 2023 Feb; 31(1):499-516. PubMed ID: 36586043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostatic stromal cells derived from benign prostatic hyperplasia specimens possess stem cell like property.
    Lin VK; Wang SY; Vazquez DV; C Xu C; Zhang S; Tang L
    Prostate; 2007 Sep; 67(12):1265-76. PubMed ID: 17597114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia.
    Polnaszek N; Kwabi-Addo B; Wang J; Ittmann M
    Prostate; 2004 Jun; 60(1):18-24. PubMed ID: 15129425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. INSL3 in the benign hyperplastic and neoplastic human prostate gland.
    Klonisch T; Müller-Huesmann H; Riedel M; Kehlen A; Bialek J; Radestock Y; Holzhausen HJ; Steger K; Ludwig M; Weidner W; Hoang-Vu C; Hombach-Klonisch S
    Int J Oncol; 2005 Aug; 27(2):307-15. PubMed ID: 16010410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urban particulate matter down-regulates filaggrin via COX2 expression/PGE2 production leading to skin barrier dysfunction.
    Lee CW; Lin ZC; Hu SC; Chiang YC; Hsu LF; Lin YC; Lee IT; Tsai MH; Fang JY
    Sci Rep; 2016 Jun; 6():27995. PubMed ID: 27313009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.